SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-18-319652
Filing Date
2018-11-06
Accepted
2018-11-06 16:57:59
Documents
2
Group Members
ISAAC MANKELIAM T. RATCLIFFENEW LEAF BPO ASSOCIATES II, L.P.NEW LEAF BPO MANAGEMENT II, L.L.C.RONALD M. HUNTVIJAY K. LATHI

Document Format Files

Seq Description Document Type Size
1 SC-13G d647068dsc13g.htm SC 13G 133137
2 EX-99.1 d647068dex991.htm EX-99.1 10114
  Complete submission text file 0001193125-18-319652.txt   145004
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Subject) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88372 | Film No.: 181163746
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address TIMES SQUARE TOWER 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address TIMES SQUARE TOWER 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 (646) 871-6400
New Leaf Biopharma Opportunities II, L.P. (Filed by) CIK: 0001735293 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G